�Researchers at Johns Hopkins are reportage what is believed to be the most conclusive evidence to date that inadequate levels of vitamin D, obtained from milk, fortified cereals and exposure to sun, lead to substantially increased risk of death.
In a study coiffure to come out in the Archives of Internal Medicine online Aug. 11, the Johns Hopkins team analyzed a diverse sample of 13,000 initially salubrious men and women participating in an ongoing national health review and compared the peril of death between those with the lowest blood levels of vitamin D to those with higher amounts. An unhealthy lack, experts say, is considered blood levels of 17.8 nanograms per cubic centimetre or lower.
Of the 1,800 study participants known to make died by Dec. 31, 2000, most 700 died from some form of heart disease, with four hundred of these being deficient in vitamin D. This translates overall to an estimated 26 percent increased risk of any death, though the number of deaths from heart disease alone was not large enough to meet scientific criteria to resolve that it was due to low vitamin D levels.
Yet, researchers say it does highlight a trend, with other studies linking shortages of vitamin D to increased rates of bosom cancer and depression in the aged. And earlier published findings by the team, from the same national study, have naturalized a possible tie-in, display an 80 percent increased risk of peripheral artery disease from vitamin D deficits.
Researchers government note that other studies in the net year or so in animals and humans have identified a connection between low levels of vitamin D and heart disease. But these studies, they say, were weakened by small sample numbers, lack of diversity in the population studied and other factors that limited scientists' ability to generalize the findings to the public at large.
"Our results make it often more clear that all men and women concerned about their overall health should more than closely monitor their rake levels of vitamin D, and work sure they have sufficiency," says subject field co-lead investigator Erin Michos, M.D., M.H.S.
"We think we have extra evidence to consider adding vitamin D deficiency as a distinct and severalise risk factor for death from cardiovascular disease, putting it alongside much better known and understood risk factors, such as age, gender, family history, smoke, high blood cholesterol levels, high blood pressure, lack of usage, obesity and diabetes," says Michos.
Vitamin D is well known to play an essential character in cell growth, in boosting the body's immune system and in strengthening bones.
"Now that we know vitamin D deficiency is a risk factor, we can better assess how aggressively to treat people at risk of heart disease or those world Health Organization are already ill and undergoing discussion," says Michos, who adds that test screening for nutrient levels is comparatively simple. It can, she says, be made section of bit blood work and through while monitoring other known risk factors, including blood pressure, glucose and lipoid levels.
Heart disease remains the nation's stellar cause of death, kill more than a gazillion Americans each year. Nearly 10 pct of those with the condition have not one identifiable, traditional risk element, which the experts say is why a considerable extent of the disease goes unexplained.
Michos, an helper professor at the Johns Hopkins University School of Medicine and its Heart and Vascular Institute, recommends that people boost their vitamin D levels by eating diets rich in such fish as sardines and mackerel, consuming fortified dairy products, taking cod-liver oil and vitamin supplements, and in warmer brave out briefly exposing skin to the sun's vitamin-D producing ultraviolet light.
Aware of the cancer risks linked to too much time worn out in the sun, she says as little as 10 to 15 proceedings of day-by-day exposure to the sun can produce sufficient amounts of vitamin D to sustain health. The hormone-like nutrient controls blood levels of calcium and phosphorus, essential chemicals in the body.
If vitamin supplements are used, Michos says thither is no evidence that more than 2,000 international units per clarence Shepard Day Jr. do any good. Study results establish that heart disease death rates planate out in participants with the highest vitamin D levels (higher up 50 nanograms per ml of blood), signaling a possible loss of the vitamin's protective effects at too-high doses.
The U.S. Institute of Medicine suggests that an decent daily uptake of vitamin D is between two hundred and four hundred international units (or blood levels nearing 30 nanograms per cubic centimeter). Previous results from the same nationwide survey showed that 41 percent of men and 53 per centum of women are technically deficient in the food, with vitamin D levels below 28 nanograms per milliliter.
Michal Melamed, M.D., M.H.S., study co-lead investigator wHO started the research as a clinical fellow at Johns Hopkins, says no one knows yet why or how vitamin D's hormone-like properties may protect the heart, but she adds that there are plenty of leads in the better known golf links the vitamin has to problems with muscle giantism and high blood insistency, in addition to its control of inflammation, which scientists are showing plays a stronger role in all kinds of heart disease. But more research is required to decide the nutrient's precise biologic action.
Researchers state their side by side steps ar to test various high doses of vitamin D to discover out if the nutritional supplementation results in fewer deaths and lower incidence of pump disease, including heart plan of attack or moments of prolonged and severe chest pain.
The team too plans to investigate what biological triggers, such as obesity or hypertension, mightiness offset or worsen the action of vitamin D on ticker muscle, or whether vitamin D sets off some other reaction in the heart.
Melamed says that because vitamin D levels are known to fluctuate in direct proportion with day-to-day physical activity, the growing epidemic of obesity and indoor sedentary lifestyles lend more urgency to act on the vitamin D factor.
Funding for this cogitation was provided by the National Institutes of Health, the P.J. Schafer Cardiovascular Research Fund and the Paul Beeson Physician Faculty Scholars in Aging Program. Michos has received previous consulting fees from vitamin D therapeutics manufacturer Abbott Pharmaceuticals. The terms of these arrangements are being managed by the Johns Hopkins University in accordance with its conflict of interest policies.
Besides Michos and Melamed, other Hopkins researchers involved in this survey, conducted entirely at Hopkins, were Wendy Post, M.D.; and Brad Astor, Ph.D. Melamed is now an assistant prof at the Albert Einstein College of Medicine of Yeshiva University in New York City.
Johns Hopkins Medicine
901 S Bond St., Ste. 550
Baltimore, MD 21231
United States
http://www.hopkinsmedicine.org
More information
